Francesca Barone

Chief Tech/Sci/R&D Officer presso CANDEL THERAPEUTICS, INC.

Patrimonio netto: 294 918 $ in data 31/03/2024

47 anni

Consumer Services

Health Technology

Posizioni attive di Francesca Barone

Società	Posizione	Inizio	Fine
CANDEL THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/11/2020	-

Società	Posizione	Inizio	Fine
Senda Biosciences, Inc. Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/05/2019	01/11/2020
University of Birmingham	Corporate Officer/Principal	01/01/2010	01/05/2019
Institute of Translational Medicine	Corporate Officer/Principal	-	-

Sapienza University of Rome	Doctorate Degree
King's College London	Doctorate Degree

Distribuzione geografica

Posizioni

Corporate Officer/Principal	3
Doctorate Degree	2
Chief Tech/Sci/R&D Officer	1

Settori

Consumer Services	4
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
CANDEL THERAPEUTICS, INC.	Health Technology

Aziende private	2
Senda Biosciences, Inc. Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA.	Health Technology
Institute of Translational Medicine